Lin, Chiao-Yun
Chao, An-Shine
Chao, Angel
Wu, Ren-Chin
Yu, Alice L.
Fu, Chiung-Hui
Teng, Yu-Chuan
Huang, Ruby Yun-Ju
Lai, Chyong-Huey https://orcid.org/0000-0002-9977-9645
Funding for this research was provided by:
National Science and Technology Council (111-2314-B-182A-088)
National Science and Technology Council (111-2314-B-182A-086)
Chang Gung Memorial Hospital, Linkou (CMRPG3M0761-2)
Chang Gung Memorial Hospital, Linkou (CMRPG3N0721-2)
Chang Gung Memorial Hospital, Linkou (OMRPG3C0018)
Yushan Young Fellow Program from Ministry of Education. (NTU-112V1402-5)
Article History
Received: 3 March 2025
Revised: 13 October 2025
Accepted: 2 January 2026
First Online: 24 January 2026
Declarations
:
: This study (IRB No.: 201702257B0) was approved by Institute Review Board (IRB) of Chang Gung Memorial Hospital (CGMH). All animal procedures were approved by the Animal Care and Use Committee of the Institutional Review Board of the Chang Gung Memorial Hospital (202102047B0, 202200254B0, 201702257B0).
: Chyong-Huey Lai received a fee from Novartis for a position on the DMC of CBYL719K12301 EPIK-O and research grants from MSD and MaNGO. Alice L Yu serves on the board of director of the OPKO Health, and owns stocks of Acepodia Biotech, OPKO Health and OBI Pharma. Angel Chao received research grants form AstraZeneca and Seagen. The other authors declare no conflict of interest.